Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Short term Debt: 2020-2024

Historic Short term Debt for MDxHealth (MDXH) over the last 5 years, with Dec 2024 value amounting to $26.4 million.

  • MDxHealth's Short term Debt rose 49.23% to $75.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 49.23%. This contributed to the annual value of $26.4 million for FY2024, which is 812.30% up from last year.
  • Latest data reveals that MDxHealth reported Short term Debt of $26.4 million as of FY2024, which was up 812.30% from $2.9 million recorded in FY2023.
  • In the past 5 years, MDxHealth's Short term Debt ranged from a high of $30.5 million in FY2022 and a low of $2.3 million during FY2022.
  • Moreover, its 3-year median value for Short term Debt was $14.7 million (2023), whereas its average is $15.5 million.
  • As far as peak fluctuations go, MDxHealth's Short term Debt plummeted by 47.60% in 2022, and later skyrocketed by 812.30% in 2024.
  • MRY analysis of 5 years shows MDxHealth's Short term Debt stood at $2.8 million in 2020, then surged by 57.59% to $4.4 million in 2021, then plummeted by 47.60% to $2.3 million in 2022, then grew by 24.41% to $2.9 million in 2023, then skyrocketed by 812.30% to $26.4 million in 2024.
  • Its Short term Debt was $26.4 million in FY2024, compared to $2.9 million in FY2023 and $2.3 million in FY2022.